168 related articles for article (PubMed ID: 12581905)
1. Burkitt lymphoma following splenic marginal zone lymphoma. evidence for two independent B-cell clones.
Heintel D; Streubel B; Welzel N; Le T; Schwarzinger I; Haas OA; Simonitsch I; Lechner K; Jaeger U
Cancer Genet Cytogenet; 2003 Feb; 141(1):86-8. PubMed ID: 12581905
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous presence of t(2;8)(p12;q24) and t(14;18)(q32;q21) in a B-cell lymphoproliferative disorder with features suggestive of an aggressive variant of splenic marginal-zone lymphoma.
Batanian JR; Dunphy CH; Richart JM; Petruska PJ; Perkins SL
Cancer Genet Cytogenet; 2000 Jul; 120(2):136-40. PubMed ID: 10942804
[TBL] [Abstract][Full Text] [Related]
3. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
4. Splenic marginal zone lymphoma with a de novo t(8;14)(q24;q32) and a prolymphocytoid evolution responsive to rituximab-bendamustine.
Scapinello G; Pizzi M; Vio S; Nabergoj M; Visentin A; Martines A; Bonaldi L; Trentin L; Semenzato G; Piazza F
Ann Hematol; 2018 Oct; 97(10):2001-2003. PubMed ID: 29728736
[No Abstract] [Full Text] [Related]
5. Primary Burkitt lymphoma of the uterine corpus.
Keller C; Savage DG; Rusta-Villa M; Bhagat G; Alobeid B
Leuk Lymphoma; 2006 Jan; 47(1):141-5. PubMed ID: 16321839
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning of complex chromosomal translocation t(8;14;12)(q24.1;q32.3;q24.1) in a Burkitt lymphoma cell line defines a new gene (BCL7A) with homology to caldesmon.
Zani VJ; Asou N; Jadayel D; Heward JM; Shipley J; Nacheva E; Takasuki K; Catovsky D; Dyer MJ
Blood; 1996 Apr; 87(8):3124-34. PubMed ID: 8605326
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
[TBL] [Abstract][Full Text] [Related]
8. The t(9;14)(p13;q32) is a recurrent but rare abnormality in splenic marginal zone lymphoma.
Kelly RJ; O'connor SJ; Barrans SL; Johnson RJ; Owen RG
Leuk Lymphoma; 2007 Aug; 48(8):1636-7. PubMed ID: 17701598
[No Abstract] [Full Text] [Related]
9. Translocation t(9;14)(p13;q32) in cases of splenic marginal zone lymphoma.
Baró C; Salido M; Domingo A; Granada I; Colomo L; Serrano S; Solé F
Haematologica; 2006 Sep; 91(9):1289-91. PubMed ID: 16956840
[TBL] [Abstract][Full Text] [Related]
10. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
[TBL] [Abstract][Full Text] [Related]
11. A novel recurrent translocation t(11;14)(p11;q32) in splenic marginal zone B cell lymphoma.
Cuneo A; Bardi A; Wlodarska I; Selleslag D; Roberti MG; Bigoni R; Cavazzini F; De Angeli C; Tammiso E; del Senno L; Cavazzini P; Hagemeijer A; Castoldi G
Leukemia; 2001 Aug; 15(8):1262-7. PubMed ID: 11480569
[TBL] [Abstract][Full Text] [Related]
12. Burkitt t(8;14)(q24;q32) and cryptic deletion in a CLL patient: report of a case and review of literature.
Reddy K; Satyadev R; Bouman D; Hibbard MK; Lu G; Paolo R
Cancer Genet Cytogenet; 2006 Apr; 166(1):12-21. PubMed ID: 16616107
[TBL] [Abstract][Full Text] [Related]
13. Mature B-cell acute lymphoblastic leukemia with associated translocations (14;18)(q32;q21) and (8;9)(q24;p13). A Burkitt variant?
Dunphy CH; van Deventer HW; Carder KJ; Rao KW; Dent GA
Arch Pathol Lab Med; 2003 May; 127(5):610-3. PubMed ID: 12708908
[TBL] [Abstract][Full Text] [Related]
14. Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features.
Burmeister T; Schwartz S; Horst HA; Rieder H; Gökbuget N; Hoelzer D; Thiel E
Leukemia; 2005 Aug; 19(8):1391-8. PubMed ID: 15973450
[TBL] [Abstract][Full Text] [Related]
15. A new dual translocation of chromosome 14 in a pediatric Burkitt lymphoma/leukemia patient: t(8;14) and t(14;15).
Quatrin M; Pasti C; Romano S; Iarossi B; Giménez V; Schuttenberg V; Costa A; Slavutsky I
Cancer Genet; 2021 Nov; 258-259():131-134. PubMed ID: 34757246
[TBL] [Abstract][Full Text] [Related]
16. Burkitt-type acute leukemia in a patient with B-prolymphocytic leukemia: evidence for a common origin.
Nguyen-Khac F; Davi F; Receveur A; Maloum K; Morel V; Le Garff-Tavernier M; Ong J; Berger R; Leblond V; Merle-Béral H
Cancer Genet Cytogenet; 2005 May; 159(1):74-8. PubMed ID: 15860362
[TBL] [Abstract][Full Text] [Related]
17. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.
Mollejo M; Menárguez J; Lloret E; Sánchez A; Campo E; Algara P; Cristóbal E; Sánchez E; Piris MA
Am J Surg Pathol; 1995 Oct; 19(10):1146-57. PubMed ID: 7573673
[TBL] [Abstract][Full Text] [Related]
18. Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones.
Lefebvre C; Fabre B; Vettier C; Rabin L; Florin A; Wang J; Gressin R; Jacob MC; Callanan M; Leroux D
Hum Pathol; 2007 Apr; 38(4):660-7. PubMed ID: 17134739
[TBL] [Abstract][Full Text] [Related]
19. Clonally related splenic marginal zone lymphoma and Hodgkin lymphoma with unmutated V gene rearrangements and a 15-yr time gap between diagnoses.
Rosenquist R; Roos G; Erlanson M; Küppers R; Bräuninger A; Hansmann ML
Eur J Haematol; 2004 Sep; 73(3):210-4. PubMed ID: 15287919
[TBL] [Abstract][Full Text] [Related]
20. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis.
Busch K; Borkhardt A; Wössmann W; Reiter A; Harbott J
Haematologica; 2004 Jul; 89(7):818-25. PubMed ID: 15257933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]